Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.

The role of cholecystokinin (CCK) has been explored in pancreatic carcinogenesis following pancreatobiliary diversion (PBD), using the specific CCK receptor antagonist CR-1409. Male Wistar rats (n = 80) weighing 70-100 g were given weekly i.p. injections of azaserine (30 mg kg-1 week-1) for 3 consec...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanapa, P., Flaks, B., Oztas, H., Deprez, P. H., Calam, J., Williamson, R. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968354/
https://www.ncbi.nlm.nih.gov/pubmed/8471422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968354/
https://www.ncbi.nlm.nih.gov/pubmed/8471422

Ejemplares similares